EC Number   |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
|---|
   2.3.1.43 | -999 |
- |
- |
486996, 486997, 486998, 487000, 487002, 487003, 487007, 487008, 661106, 671676 |
| 2.3.1.43 | -999 |
- |
activities produced by different lung cell clones expressing the enzyme |
663302 |
| 2.3.1.43 | -999 |
- |
activity of LCAT in men with cardiovascular disease, CVD, compared to healthy men, overview. Plasma LCAT activity is 5% higher in CVD cases in association with higher total cholesterol, non-HDL cholesterol and triglycerides, re-adjusted incident CVD is increased with higher LCAT activity, overview |
701993 |
| 2.3.1.43 | -999 |
- |
activity of the wild-type and two naturally occurring mutant enzymes |
487027 |
| 2.3.1.43 | -999 |
- |
activity with 80 and 93 A HDL particles, and with wild-type and different mutant of apolipoprotein A-I, overview |
661198 |
| 2.3.1.43 | -999 |
- |
acyltransferase and esterase activities of several truncated recombinant enzymes |
487013 |
| 2.3.1.43 | -999 |
- |
assay methods |
486979, 486980, 486993 |
| 2.3.1.43 | -999 |
- |
cholesterol esterification and phospholipase A2 activities of wild-type and mutant enzymes with different substrates, overview |
661064 |
| 2.3.1.43 | -999 |
- |
diabetic pregnant rats, Isio-4-fed, show a significant reduction of serum LCAT activity compared to control rats. Isio-4-fed macrosomic pups present a significant increase in serum LCAT activity compared to controls. EPAX diet significantly increases LCAT activity in diabetic dams, whlie it induces a decrease in this activity in macrosomic pups |
686933 |
| 2.3.1.43 | -999 |
- |
enzyme activities with apolipoprotein A-I and Apo AI-derived peptides DRV, KLL, and VLES, overview |
735598 |
